print PRINT

SCIENCE > Health

UK drug maker starts clinical trial of COVID-19 vaccine in Japan

  • September 5, 2020
  • , Nikkei
  • JMH Summary

According to Saturday’s Nikkei, UK pharmaceutical company AstraZeneca has launched in Japan a clinical test of its coronavirus vaccine, saying that some 250 healthy people aged 18 or over will participate in the two-stage trial conducted at several hospitals. The drug manufacturer is reportedly aiming to supply 30 million doses of its COVID 19 vaccine to the Japanese market by next March.

  • COVID-19
  • OPINION POLLS
  • Trending Japan